This clinical trial aims to evaluate if nano-hydroxyapatite (Nano-HA) toothpaste effectively treats children with Molar-Incisor Hypomineralization (MIH). It will also assess the safety of Nano-HA toothpaste. The main questions are:
* Does Nano-HA toothpaste reduce caries incidence, improve tooth aesthetics, and decrease hypersensitivity?
* How does Nano-HA compare to fluoridated toothpaste in terms of outcomes?
Participants will:
* Use Nano-HA or fluoridated toothpaste daily for 12 months.
* Visit the clinic for checkups and evaluations every 1 to 3 months.
* Record symptoms, brushing compliance, and sensitivity.
The study will compare Nano-HA toothpaste to fluoridated toothpaste to determine its efficacy in managing MIH .